What will be, will be. Really hadn't concerned myself as to whether LTR is in the ASX 200. Right now I'm think the only thing on BOD's mind is the DFS and getting the fundamentals right. I am also more interested what happens here:
Have they created market interest with the EV makers ?
How they will price their lithium asset ?
How they will look to realise full value ? Are they going to use the RMX platform for sales and if so how much ? Would they go as far as to have future contracts sold on the RMX platform ?
What are the capital costs and lead times to order equipment ?
Financing the project > Capital Raise, or Find a company that is willing to invest for a small percentage by way of lithium !!
Can they get the plant built sooner ? Cost versus benefit ?
There are so many things I'm more interested about seeing more information as LTR move into the next phase.
SP is somewhat a distraction. Fact is this is going to be worth north of $15 come 2024. I'm using some analysis from another poster at EBITDA.
All of the above is what will truely drive the share price.
- Forums
- ASX - By Stock
- LTR
- ASX Today
ASX Today, page-11138
-
- There are more pages in this discussion • 30,480 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add LTR (ASX) to my watchlist
|
|||||
Last
97.0¢ |
Change
-0.030(3.00%) |
Mkt cap ! $2.352B |
Open | High | Low | Value | Volume |
$1.03 | $1.03 | 96.5¢ | $13.68M | 13.82M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
9 | 76446 | 96.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
97.5¢ | 50000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
7 | 54268 | 0.965 |
16 | 448006 | 0.960 |
10 | 273881 | 0.955 |
34 | 357765 | 0.950 |
7 | 148508 | 0.945 |
Price($) | Vol. | No. |
---|---|---|
0.975 | 50000 | 1 |
0.980 | 30256 | 2 |
0.985 | 5873 | 2 |
0.990 | 28958 | 4 |
0.995 | 8676 | 3 |
Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
Featured News
LTR (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online